Szucs T D
Department of Internal Medicine, Ludwig Maximilian's University, Munich, Germany.
Pharmacoeconomics. 1995;8 Suppl 1:62-7. doi: 10.2165/00019053-199500081-00014.
This article focuses on the overall situation with regard to healthcare financing in the field of diabetes. Worldwide efforts on cost containment have severely influenced the management of chronic illness. An answer as to whether or not the expected financial crisis can be prevented will be difficult to obtain. However, use of the modern tools of management sciences and health economics can bring more transparency into the picture. Solutions will have to be based increasingly on empirical economic data, which, so far, are only in the process of being generated in many countries. A research agenda is proposed that might trigger the compilation of additional data in order to ensure adequate future financing of diabetes care.
本文聚焦糖尿病领域医疗保健融资的整体情况。全球控制成本的努力严重影响了慢性病的管理。很难确定是否能够预防预期的金融危机。然而,运用管理科学和健康经济学的现代工具可以使情况更加透明。解决方案将越来越多地基于实证经济数据,而目前许多国家才刚刚开始收集这些数据。本文提出了一个研究议程,可能会促使收集更多数据,以确保未来有足够的资金用于糖尿病护理。